AstraZeneca plans to apply for regulatory approval for Blood Pressure Drug Baxdrostat before the end of this year, with approval expected in the U.S. and E.U. in 2026. The company views the opportunity in Baxdrostat as the crux of its strategy...
Novavax declared that the U.S. Food and Drug Administration (FDA) has given its nod to the updated Nuvaxovid 2025-2026 Formula to stop COVID-19.
Mahajan Imaging & Labs, a pioneer in integrated diagnostics and advanced medical imaging, has entered a strategic alliance with Fortis La Femme, India’s leading hospital dedicated to women’s and children’s health, to create a new benchmark in...
India is scheduled to overhaul the regulations under the Biological Diversity Act, 2002 with the intention of boosting the ayurvedic medicine
Davaindia, one of India’s largest and fastest-growing retail pharmacy chains, has taken its e-commerce services in Jaipur, and is building the company’s digital presence. This move brings the generics-driven retailer's total online presence to more..
Aurobindo Pharma announced today that its wholly owned subsidiary Apitoria Pharma received a Form 483 with five observations from the US Food and Drug Administration (FDA). The form was received after the agency performed an inspection of its...
Sai Life Sciences, a Contract Research, Development, and Manufacturing Organization (CRDMO) focused on innovation, has announced the successful completion of Phase II of its new Production Block (PB-11) at the company’s primary API manufacturing
Eli Lilly and Company announced positive top-line results in the Phase 3 ATTAIN-2 trial that evaluated, orforglipron, an investigational oral GLP-1 receptor agonist in adults with obesity or overweight and type 2 diabetes. The ATTAIN-2 trial showed
The plan to combine these separately listed businesses under the Dr. Agarwal's Group has been accepted by the boards of directors of Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL).
Bristol Myers Squibb presented major clinical and real-world results of its cardiovascular line at the European Society of Cardiology (ESC) Congress, which took place between August 29 and September 1, 2025, in Madrid, Spain. New data on Camzyos (mav
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")